CL2018002646A1 - Prevención de la adherencia del tejido biológico. - Google Patents

Prevención de la adherencia del tejido biológico.

Info

Publication number
CL2018002646A1
CL2018002646A1 CL2018002646A CL2018002646A CL2018002646A1 CL 2018002646 A1 CL2018002646 A1 CL 2018002646A1 CL 2018002646 A CL2018002646 A CL 2018002646A CL 2018002646 A CL2018002646 A CL 2018002646A CL 2018002646 A1 CL2018002646 A1 CL 2018002646A1
Authority
CL
Chile
Prior art keywords
biological tissue
adhesion
self
prevention
assembling peptide
Prior art date
Application number
CL2018002646A
Other languages
English (en)
Spanish (es)
Inventor
Satoru Kobayashi
Original Assignee
3 D Matrix Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 3 D Matrix Ltd filed Critical 3 D Matrix Ltd
Publication of CL2018002646A1 publication Critical patent/CL2018002646A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/04—Macromolecular materials
    • A61L31/043—Proteins; Polypeptides; Degradation products thereof
    • A61L31/047—Other specific proteins or polypeptides not covered by A61L31/044 - A61L31/046
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/04—Macromolecular materials
    • A61L31/043—Proteins; Polypeptides; Degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L31/145—Hydrogels or hydrocolloids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L31/16—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods
    • A61B2017/00743—Type of operation; Specification of treatment sites
    • A61B2017/00818—Treatment of the gastro-intestinal system
    • A61B2017/00823—Appendectomy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods
    • A61B2017/00831—Material properties
    • A61B2017/00893—Material properties pharmaceutically effective

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Surgery (AREA)
  • Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dispersion Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Molecular Biology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Rheumatology (AREA)
  • Materials For Medical Uses (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
CL2018002646A 2016-03-18 2018-09-14 Prevención de la adherencia del tejido biológico. CL2018002646A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201662310121P 2016-03-18 2016-03-18
US201662310131P 2016-03-18 2016-03-18

Publications (1)

Publication Number Publication Date
CL2018002646A1 true CL2018002646A1 (es) 2019-07-05

Family

ID=58645327

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2018002646A CL2018002646A1 (es) 2016-03-18 2018-09-14 Prevención de la adherencia del tejido biológico.

Country Status (11)

Country Link
US (4) US20190091376A1 (https=)
EP (1) EP3429653B1 (https=)
JP (1) JP7049557B2 (https=)
KR (1) KR20190022455A (https=)
CN (1) CN109152868A (https=)
AU (2) AU2017232540A1 (https=)
BR (1) BR112018068941A2 (https=)
CA (1) CA3017684A1 (https=)
CL (1) CL2018002646A1 (https=)
MX (1) MX2018011121A (https=)
WO (1) WO2017158420A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112018068941A2 (pt) 2016-03-18 2019-04-16 3-D Matrix, Ltd. prevenção de adesão de tecidos biológicos
EP3818071A2 (en) 2018-07-03 2021-05-12 3-D Matrix, Ltd. Ionic self-assembling peptides
CN115397454A (zh) 2020-03-31 2022-11-25 立美基股份有限公司 通过辐照对自组装肽进行灭菌
KR20250155730A (ko) * 2024-04-24 2025-10-31 경희대학교 산학협력단 하지정맥 수술시 정맥 내벽의 기계 화학적 절제장치

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5255274B2 (ja) * 2004-07-06 2013-08-07 スリーディー マトリックス， インコーポレイテッド 精製両親媒性ペプチド組成物およびその使用
DK1879606T3 (da) * 2005-04-25 2013-09-23 Massachusetts Inst Technology Selvorganiserende peptider til fremme af hæmostase
US9162005B2 (en) * 2005-04-25 2015-10-20 Arch Biosurgery, Inc. Compositions for prevention of adhesions and other barrier applications
RU2011118341A (ru) * 2008-10-06 2012-11-20 3-Д Матрикс, Лтд. (Jp) Агент для окклюзии тканей
JP6034868B2 (ja) * 2011-09-02 2016-11-30 株式会社スリー・ディー・マトリックス 胸部の空気漏れ閉塞のための両親媒性ペプチド
US20160287744A1 (en) * 2012-11-14 2016-10-06 3-D Matrix Ltd. Vascular embolic system
HK1220145A1 (zh) * 2013-03-14 2017-04-28 3-D Matrix, Ltd 胆漏治疗
BR112018068941A2 (pt) 2016-03-18 2019-04-16 3-D Matrix, Ltd. prevenção de adesão de tecidos biológicos
EP3429646A1 (en) 2016-03-18 2019-01-23 3-D Matrix, Ltd Pancreatic fistula occlusion
MX2018011201A (es) 2016-03-18 2018-11-22 3 D Matrix Ltd Oclusion de fuga de liquido cefalorraquideo.

Also Published As

Publication number Publication date
AU2021225225A1 (en) 2021-09-30
JP7049557B2 (ja) 2022-04-07
KR20190022455A (ko) 2019-03-06
US20250177614A1 (en) 2025-06-05
MX2018011121A (es) 2019-01-31
CA3017684A1 (en) 2017-09-21
JP2019508184A (ja) 2019-03-28
US20190091376A1 (en) 2019-03-28
US12377196B2 (en) 2025-08-05
AU2017232540A1 (en) 2018-09-27
EP3429653B1 (en) 2022-11-09
US20230241294A1 (en) 2023-08-03
CN109152868A (zh) 2019-01-04
WO2017158420A1 (en) 2017-09-21
US20220111126A1 (en) 2022-04-14
BR112018068941A2 (pt) 2019-04-16
EP3429653A1 (en) 2019-01-23

Similar Documents

Publication Publication Date Title
CL2018002646A1 (es) Prevención de la adherencia del tejido biológico.
MX2017008713A (es) Sujetadores quirurgicos curvados que se usan para fijar dispositivos protesicos en los tejidos.
EP3614946A4 (en) DETERMINATION OF THE NATURE OF CONTACT BETWEEN THE CATHETER TIP AND TISSUE
MX2024000348A (es) Mavacamten para su uso en el tratamiento de la cardiomiopatia hipertrofica.
CL2016001405A1 (es) A peptide mixture
PE20200748A1 (es) Composiciones de aminoacidos para el tratamiento de lesion neuronal
CL2018002644A1 (es) Oclusión fístula pancreática.
CL2020000382A1 (es) Composiciones de aminoácidos para el tratamiento de enfermedad hepática.
MX2016014050A (es) Combinacion de un acido hialuronico y un polisacarido sulfatado.
PL3226854T3 (pl) Kompozycja na bazie aminokwasów do odbudowy fibroelastyny w tkance łącznej skóry
MX2015010139A (es) Composicion antiseptica oral para tratamiento de mucositis oral.
CY1120642T1 (el) Φαρμακευτικη συνθεση της ιβουπροφαιμνης και της τραμαδολης για οφθαλμολογικη χρηση
EA202191686A1 (ru) Гидролизат коллагена для применения против кожных болезней и кишечных заболеваний
CY1117854T1 (el) Πεπτιδικη φαρμακοτεχνικη μορφη για τοπικη οφθαλμικη χρηση
MX2018012285A (es) Metodos de tratamiento para enfermedades colestasicas y fibroticas.
MX2019005979A (es) Peptidos modificados.
WO2016040169A3 (en) Mucolytic agents for use in tretaing pulmonary sarcoidosis
MX2019006444A (es) Métodos de tratamiento de artropatía hemofílica utilizando factores de coagulación quiméricos.
GB2558315A (en) Patterned surfaces
MX2022014577A (es) Gel intestinal de levodopa y carbidopa y metodos de uso.
EP3787496C0 (en) DETECTION OF IRREGULARITIES IN BREAST TISSUE
MX2019009909A (es) Composiciones farmaceuticas para terapia de combinacion.
CL2018002643A1 (es) Oclusión de fuga de líquido cefalorraquideo.
EP3446723A4 (en) DENTAL TREATMENT MATERIAL AND DENTAL HANDLING KIT
CO2022010207A2 (es) Uso de derivados del ácido hialurónico en la regeneración de tejidos óseos y cartilaginosos